B Lymphocyte–Induced Maturation Protein-1 Contributes to Intestinal Mucosa Homeostasis by Limiting the Number of IL-17–Producing CD4+ T Cells
暂无分享,去创建一个
S. Targan | E. Meffre | J. Silva | G. Martins | D. Dhall | Deepti Dhall | Soofia Salehi | Rashmi Bankoti | Luciana Benevides | Jessica Willen | Michael Couse | Joao S Silva | Eric Meffre | Stephan Targan | Gislâine A Martins | L. Benevides | Jessica Willen | Michael Couse | R. Bankoti | Soofia Salehi
[1] E. Meffre,et al. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. , 2009, Immunity.
[2] M. Neurath,et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue , 2007, Nature Protocols.
[3] K. Calame,et al. B Lymphocyte-Induced Maturation Protein (Blimp)-1, IFN Regulatory Factor (IRF)-1, and IRF-2 Can Bind to the Same Regulatory Sites1 , 2004, The Journal of Immunology.
[4] V. Kuchroo,et al. Induction and effector functions of TH17 cells , 2008, Nature.
[5] K. Calame,et al. Regulation and functions of Blimp-1 in T and B lymphocytes. , 2008, Annual review of immunology.
[6] A. Adamson,et al. Signal transduction and Th17 cell differentiation. , 2009, Microbes and infection.
[7] S. Mullaly,et al. Activating and inhibitory functions for the histone lysine methyltransferase G9a in T helper cell differentiation and function , 2010, The Journal of experimental medicine.
[8] F. Powrie,et al. Induction of Inflammatory Bowel Disease in Immunodeficient Mice by Depletion of Regulatory T Cells , 1999, Current protocols in immunology.
[9] S. Nutt,et al. Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance , 2006, Nature Immunology.
[10] Brigitta Stockinger,et al. Effector T cell plasticity: flexibility in the face of changing circumstances , 2010, Nature Immunology.
[11] K. Calame,et al. Transcriptional repressor Blimp-1 regulates T cell homeostasis and function , 2006, Nature Immunology.
[12] K. Calame,et al. Blimp-1 Attenuates Th1 Differentiation by Repression of ifng, tbx21, and bcl6 Gene Expression , 2008, The Journal of Immunology.
[13] Francis J. Huber,et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. , 2011, Immunity.
[14] F. Powrie,et al. Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis1 , 2006, The Journal of Immunology.
[15] T. Malek,et al. Cytokine-Dependent Blimp-1 Expression in Activated T Cells Inhibits IL-2 Production1 , 2007, The Journal of Immunology.
[16] Todd Davidson,et al. Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling , 2010, Nature.
[17] R. Nurieva,et al. Transcription of Il17 and Il17f is controlled by conserved noncoding sequence 2. , 2012, Immunity.
[18] C. Elson,et al. Late developmental plasticity in the T helper 17 lineage. , 2009, Immunity.
[19] D. Littman,et al. Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.
[20] F. Sallusto,et al. Human Th17 cells in infection and autoimmunity. , 2009, Microbes and infection.
[21] A. Rudensky,et al. CD4+ Regulatory T Cells Control TH17 Responses in a Stat3-Dependent Manner , 2009, Science.
[22] R. D. Hatton,et al. Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.
[23] R. J. Hocking,et al. TGFb in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells , 2022 .
[24] N. Heintz,et al. A rapid method for targeted modification and screening of recombinant bacterial artificial chromosome. , 2001, Journal of immunological methods.
[25] D. Bending,et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. , 2009, The Journal of clinical investigation.
[26] R. J. Hocking,et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.
[27] Warren Strober,et al. Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17–producing T cells , 2008, Nature Immunology.
[28] K. Calame,et al. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. , 2003, Immunity.
[29] Ying Wang,et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.
[30] R. D. Hatton,et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. , 2007, Annual review of immunology.
[31] K. Calame,et al. Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival , 2008, The Journal of experimental medicine.
[32] Gary D. Stormo,et al. The AP-1 transcription factor Batf controls TH17 differentiation , 2009, Nature.
[33] M. Raffatellu,et al. Th17 Cytokines and the Gut Mucosal Barrier , 2010, Journal of Clinical Immunology.
[34] W. Paul,et al. Differentiation of effector CD4 T cell populations (*). , 2010, Annual review of immunology.
[35] A. Rudensky,et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. , 2011, Immunity.
[36] W. Shi,et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells , 2011, Nature Immunology.
[37] F. Powrie,et al. Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells , 2010, Immunity.
[38] L. Cosmi,et al. Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursor , 2008, The Journal of experimental medicine.
[39] P. Miossec. IL-17 and Th17 cells in human inflammatory diseases. , 2009, Microbes and infection.
[40] T. Kitamura,et al. Plat-E: an efficient and stable system for transient packaging of retroviruses , 2000, Gene Therapy.
[41] H. Weiner,et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.
[42] Chen Dong,et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. , 2008, Immunity.
[43] Kathryn Roeder,et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci , 2010, Nature Genetics.
[44] K. Wright,et al. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing , 2004, Nature Immunology.
[45] D. Littman,et al. The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt , 2008, Nature Immunology.
[46] Johan Van Limbergen,et al. Common variants at five new loci associated with early-onset inflammatory bowel disease , 2009, Nature Genetics.
[47] D. Littman,et al. Transcriptional regulatory networks in Th17 cell differentiation. , 2009, Current opinion in immunology.
[48] D. Levy,et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways , 2007, Nature Immunology.
[49] Brigitta Stockinger,et al. The functional plasticity of T cell subsets , 2009, Nature Reviews Immunology.
[50] Gisen Kim,et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis , 2009, Nature Immunology.
[51] L. Cosmi,et al. Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.
[52] D. Littman,et al. The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.